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Abstract: Reflectance confocal microscopy (RCM) is a non-invasive high-resolution optical
imaging technique used in clinical settings as a diagnostic method. However, RCM has limited
diagnostic ability by providing non-specific morphological information only based on reflection
contrast. Various multimodal imaging techniques have been developed to compensate the
limitations of RCM, but multimodal techniques are often slow in imaging speed compared to
RCM alone. In this report, we combined RCM with moxifloxacin based two-photon microscopy
(TPM) for high-speed multimodal imaging. Moxifloxacin based TPM used clinically compatible
moxifloxacin for cell labeling and could do non-invasive cellular imaging at 30 frames/s together
with RCM. Performance of the combined microscopy was characterized in the imaging of mouse
skin and cornea, in vivo. Detail tissue microstructures including cells, extra-cellular matrix
(ECM), and vasculature were visualized. The combined microscopy was applied to human
skin cancer specimens, and both cells and ECM in the skin cancer and normal skin regions
were visualized at high imaging speeds. The combined microscopy can be useful in the clinical
applications of RCM by providing multiple contrasts.
© 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement
1. Introduction
Reflectance confocal microscopy (RCM) is a 3D imaging technique based on light reflection
from samples. RCM has been used as a diagnostic method in clinical settings by providing
high-resolution cellular images non-invasively [1–7]. In dermatology, RCM has been used for
non-invasive detection of skin cancer boundary to guide the surgery of non-melanoma skin cancers
[2–5]. In ophthalmology, RCM has been used for non-invasive detection of infecting pathogens
in the diagnosis of corneal keratitis and other ocular surface complications [6,7]. However, RCM
has limitations in the clinical applications by providing morphological information based on
reflection contrast. Reflection contrast is usually not sensitive for detecting small lesions in
disease tissues due to the disruption of micro-structures. Even if reflection contrast provides
clear visualization, morphological information from RCM may not be specific to detect cells of
interest or infecting pathogens. Microstructures of similar morphologies as target pathogens may
exist and they may not be distinguished by RCM.
In order to overcome the limitations of RCM, multimodal techniques have been developed
to provide additional contrasts or information together with reflection contrast [8–17]. RCM
was combined with fluorescence confocal microscopy (FCM) for simultaneous reflection and
fluorescence imaging [8–11]. However, the RCM and FCM combination is usually not applicable
to human due to the toxicity of exogenous labeling agents used in FCM, unless FCM imaging is
based on tissue auto-fluorescence (AF) or FDA approved contrast agents such as fluorescein and
indocyanine green (ICG). Two-photon microscopy (TPM), which is another 3D fluorescence
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microscopy based on nonlinear two-photon excitation of fluorophores, was combined with RCM
for imaging based on both reflection and AF [12–15,18]. TPM can image cells and extra-cellular
matrix (ECM) including collagen in tissues without exogenous labeling by using AF and second
harmonic generation (SHG). However, label-free TPM is slow compared to RCM by using weak
AF and SHG. Raman spectroscopy was combined with RCM for simultaneous structural imaging
and chemical vibrational spectrum measurement [16,17].
Recently, we introduced moxifloxacin as a clinically compatible cell labeling agent for TPM.
Moxifloxacin is a 4th generation fluoroquinolone antibiotic used either to treat or to prevent
infection in the eye and lung [19]. Pharmacokinetic studies of moxifloxacin showed relatively fast
penetration into biological tissues and high intracellular distribution, which are good for tissue
labeling [19]. Moxifloxacin has intrinsic florescence, excited at ultraviolet wavelength. Nonlinear
two-photon and three-photon excitations of moxifloxacin were demonstrated with near-infrared
(NIR) excitation wavelengths from 700nm to 800nm [19–21] and at 1053 nm [22], respectively.
With moxifloxacin application, TPM could image approximately 10 times faster than label-free
TPM [19]. Moxifloxacin based TPM of various ex-vivo skin cancer tissues visualized specific
cellular features at a relatively high speed [23]. Moxifloxacin labeled the cell cytoplasm in
case of epithelial cells and both the cell cytoplasm and nucleus in case of stromal cells [19].
Moxifloxacin TPM might be able to be used together with RCM for high-speed multimodal
imaging.
In this report, we developed a combined reflectance confocal (RC) and moxifloxacin based two-
photon (TP) microscopy for multi-contrast high-speed tissue imaging. The combined microscopy
was based on high-speed TPM using a resonant scanner and an additional confocal reflection
channel. The combined microscopy was characterized and then applied to multi-contrast imaging
of the mouse skin and cornea, in vivo. Then, the combined microscopy was used to image human




A simplified schematic of the combined microscopy is shown in Fig. 1. The combined microscopy
was based on high-speed TPM using a resonant scanner running at 8 KHz, and an additional
channel for confocal reflection detection. The system had two fluorescence channels to resolve
moxifloxacin fluorescence and SHG, and a reflection channel. The combined microscopy used
a Ti-Sapphire laser (Chameleon II, 140fs, Coherent) as the light source for both fluorescence
and reflection imaging. The laser beam from the source first passed through a power control
unit, consisting of a motorized half wave plate (HWP, 10RP52-4, Newport) and a polarizer
(PL, GL5-B, Thorlabs). After the power control unit, the laser beam was expanded by a lens
pair (f= 50mm & 100mm) in 4f configuration and passed a beam splitter (50:50), which was
installed to collect reflected light from the sample. The transmitted laser beam went to the
combination of a resonance scanner and a galvanometer scanner for 2 axis scanning. After the
scanner combination, the laser beam was expanded by the combination of a scan lens (f=50mm)
and a tube lens (f=200mm). The excitation beam was transmitted through a long-pass dichroic
mirror (700LP, Chroma) and went to an objective lens (XLUMPLFN 20x, 1NA, 2mm WD,
water immersion, Olympus Inc.). The objective lens focused the excitation laser into the sample.
The excitation focus scanned the sample in the transverse plane with the Galvo & Resonant
scanner combination. Axial scanning was performed with a piezoelectric objective translator
(209SRG&P-725-4CD, PI). Emission light from the sample was collected by the objective lens,
reflected on the dichroic mirror, passed through a barrier filter (680SP, Chroma), spectrally split
by a dichroic mirror (450SP, Chroma) and emission filters (390nm – 410nm, Thorlabs), and then
collected at two photomultiplier tubes (PMTs, H10770A-40, Hamamatsu). The two fluorescence
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channels collected moxifloxacin fluorescence and SHG light separately. Signals from the PMTs
were fed into transimpedance amplifier (DHPCA-100, Femto) and then a data acquisition board
(NI-5734, National Instrument). Reflected light from the sample was also collected by the
objective lens and transmitted through the dichroic mirror and the lens pair, reflected on the
scanner for de-scanning, and then partially reflected on the beam splitter. De-scanned reflected
light was focused by a lens (f= 50mm), transmitted through a pin hole (15µm, Thorlabs), and
then collected by a PMT (R5929, Hamamatsu). Signal from the PMT was fed into an amplifier
(C6438, Hamamatsu), and then the acquisition board. Signal acquisition in the RC, TPF and SHG
channels was performed simultaneously. Laser scanning and data acquisition were controlled by
an output board (National Instruments), and Scanimage software (Vidrio Technology).
Fig. 1. Schematic of RC and TP combined microscopy
Both RC and moxifloxacin TP images were acquired at 31 frames/s. Both images typically had
the field of view (FOV) of 470 µm x470 µm consisting of 512× 512 pixels. 3D volumetric images
were obtained by acquiring multiple transverse plane images with stepwise axial increment by 1
µm. Excitation wavelength was 790 nm and excitation power was approximately 11mW. Image
resolution was characterized by 3D imaging fluorescent microspheres (0.2 µm in diameter, F8811,
Invitrogen) embedded in 2% agarose gel and by analyzing intensity profiles in both the transverse
and axial directions. Image resolution was measured as full width at half maximum intensity
(FWHM) from the intensity profile. RC imaging showed the image resolution of 0.7 µm and
2.4 µm in the lateral and axial directions respectively. TP imaging showed the image resolution
of 0.7 µm and 3.0 µm in the lateral and axial direction respectively. The image resolution in
both RC and TP imaging was less than the theoretical one based on the numerical aperture of
the objective lens due to the underfilling of excitation laser beam on the back aperture of the
objective lens. RC and TP images were post processed in MATLAB (MathWorks) with a block
matching 3D filter for de-noising [24].
2.2. Sample preparation
In this study, 8-week old female hairless mice (SKH1-HrHr, ORIENT BIO Inc, Korea) were
used. During the imaging, mice were anesthetized by inhaling gas mixture of 1.5%/vol isoflurane
(Terrel, Piramal) and medical grade oxygen. A heating plate (Chamlide TR, Live cell Instrument,
Korea) was used to maintain the body temperature at 37°C during the anesthesia. Custom-made
holders were used for in vivo imaging of the mouse cornea and ear to minimize breathing motion
during imaging [25]. Moxifloxacin ophthalmic solution (Vigamox, Alcon Laboratories, Fort
Worth, US, 12.4 mM) was used to label tissues prior TP imaging. In case of the skin, the stratum
corneum was removed via gentle tape stripping before moxifloxacin application, and then drops
of moxifloxacin solution were instilled for 20 minutes. In case of the cornea, single drop of
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moxifloxacin solution was instilled and then eye lids were closed for 5 minutes. Remaining
moxifloxacin on both skin and cornea surface was removed by washing with phosphate buffered
solution (PBS). The combined RC and TP imaging was conducted in either 3D or time lapse
mode.
Ex-vivo human basal cell carcinoma (BCC) specimens were used to test the feasibility of
multi-contrast imaging. Human skin specimens were collected at Severance Hospital of Yonsei
University (Seoul, Rep. of Korea) in January 2019. The acquired specimens were imaged in
fresh condition within 12 hours after collection. BCC samples were imaged after immersion in
moxifloxacin ophthalmic solution for 5 minutes. Remaining moxifloxacin on the sample surface
was removed by washing with PBS. BCC diagnosis was histopathologically confirmed. The
study protocol was approved by the Institutional Review Board of Yonsei University, Severance
Hospital. This study was conducted in compliance with Declaration of Helsinki. Personal
information of patient was anonymized and de-identified before analysis.
3. Results
3.1. Combined moxifloxacin TP and RC imaging of the mouse skin, in vivo
The combined microscopy was characterized in the imaging of mouse skin, in vivo. Mouse ear
skin was imaged in either 3D or single planes, and representative 3D images are shown in Fig. 2.
En-face moxifloxacin TP and RC images at 6 different depths covering the epidermis and dermis
are shown (4µm, 16µm, 24µm, 41µm, 64µm, 105µm deep from the surface). Moxifloxacin TP
images were made by combining two-photon fluorescence (TPF) of moxifloxacin and intrinsic
SHG in two different colors of green and blue respectively. In the epidermis, epidermal cells
appeared both in the TPF and RC channels. Epidermal cells were large and flat in the superficial
epidermis (Fig. 2(a)) and small in the basal epidermis (Fig. 2(b)). In the TPF channel, individual
cells were resolved with high moxifloxacin fluorescence in the cell cytoplasm and no fluorescence
in the cell nucleus. In the RC channel, individual cells were resolved with relatively high reflection
on the cell membrane. In the dermis, dermal cells and collagen were shown in the TPF/SHG
channel and fibrous ECM structures and vessels were shown in the RC channel (Fig. 2(c, d))
Scattered cells in the dermis were shown in the TPF channel with moxifloxacin labeling, while
they were not visible in the RC channel. Cell clusters in the hair follicles were shown in the
TPF channel. Collagen in ECM was visualized in the SHG channel. Fibrous ECM structures
were clearly visible in the RC channel. Relatively large fibrous structure and collagen content
in ECM were visualized by the combination of SHG and RC channel images. Blood vessels
were shown in both the RC and TPF/SHG channel (Fig. 2(d, e), red arrows). Blood vessels were
clearly identified in the RC channel video (Visualization 1) owing to the temporal change of
speckles during imaging associated with blood flow. Blood vessels appeared with relatively strong
reflection on the top surface of blood vessels and weak reflection inside in the RC channel. Blood
vessels appeared partially in the TPF/SHG channel with moxifloxacin labeling of endothelial
cells. Large blood vessels deep inside the skin appeared in the RC channel (Fig. 2(f), red arrows)
only, probably because moxifloxacin did not penetrate enough and collagen SHG signal was
also very weak at this depth due to the scattering of excitation light. There were other structures
which appeared empty in both the RC and TPF/SHG channels (Fig. 2(e), yellow arrows). The
structures were much larger than nearby blood vessels and had no reflection and no SHG inside.
These empty structures could be lymphatic vessels which were reported in the literature [26,27].
Cellular structure in the epithelium were accessible in both the RC and TPF channel images.
In the dermis, cells and collagen were visualized in the TFP/SHG channel and fibrous ECM
structure and vessels were visualized in the RC channel. Combination of TPF/SHG and RC
channel images clearly visualized microenvironments in the skin by imaging cells, ECM, and
blood and lymphatic vessels.
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Fig. 2. In vivo 3Dmoxifloxacin TP and RC images of the mouse ear pinna skin (Visualization
1). En-face moxifloxacin TP (A1 - F1) and RC (A2 – F2) images at 6 different depths of
4µm, 16µm, 24µm, 41µm, 64µm, 105µm from the skin surface are shown. (A1, 2): the
stratum corneum, (B1, 2): the basal layer, (C1, 2 – F1, 2): the dermis at 3 different depths.
TP images are color-coded in green and blue scales for moxifloxacin fluorescence and SHG,
respectively. RC images are color-coded in gray scale. Blood and lymphatic vessels in the
dermis are marked with red and yellow arrowheads, respectively.
3.2. Combined moxifloxacin TP and RC imaging of the mouse cornea, in vivo
The cornea is another application field of RCM: non-invasive and early diagnosis of corneal
infection by detecting infecting pathogens. The combined microscopy was applied to normal
mouse cornea, in vivo and results are shown in Fig. 3. Combined moxifloxacin TP and RC images
visualized cells and ECM in the epithelium (Fig. 3(a-c)), stroma (Fig. 3(d)), and endothelium
(Fig. 3(d)) of the mouse cornea by using different contrasts. En-face corneal images in Fig. 3 were
flattened to show individual corneal layers from the raw images taken from the curved corneal
surface. Some breathing motion appeared as wavy patterns in the flattened images (Fig. 3(a1)).
In the epithelium, relatively large and flat cells in the superficial epithelium (Fig. 3(a)) and small
cells in the basal epithelium (Fig. 3(b, c)) were shown in both the TPF and RC channels. In
the TPF channels, epithelial cells expressed relatively uniform moxifloxacin fluorescence in the
cell cytoplasm. Individual cells were resolved with relatively weak fluorescence on the cell
boundaries and the intensity variation among cells. In the RC channel, cells were resolved by
relatively high reflection on the cell boundaries owing to refractive index mismatch. Cells in
the basal epithelium were resolved more clearly compared to those in the superficial epithelium,
because cells in the basal epithelium were small and elongated compared to the ones in the
superficial epithelium. Sub-basal nerve plexuses were also observed in both the moxifloxacin
TP and RC channels, although they appeared clearly in the RC channel owing to high reflection
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associated with refractive index mismatch (Fig. 3(c)). In the stroma, cells like keratocytes
and nerves and collagen were visualized. Cells appeared in both the TPF and RC channels by
expressing moxifloxacin fluorescence and relatively high reflection, and collagen appeared only
in the SHG channel (Fig. 3(d)). Cells were visible clearly in the RC channel with relatively high
reflection, and nuclei of the cells were visible in the TPF channel. In the endothelium, cells
appeared clearly in the RC channel, while did not appeared in the TPF channel probably due to
the insufficient moxifloxacin labeling. In the normal mouse cornea, cells in all the corneal layers
were clearly visualized in the RC channel and visualized in the TPF channel with additional
fluorescence contrast. Collagen in the stroma was visualized in the SHG channel. Although
RC contrast was enough to visualize most of cellular structure in the normal cornea, additional
contrasts of cells and collagen will be useful for the imaging of diseased turbid corneas.
Fig. 3. In vivo 3D moxifloxacin TP and RC images of the mouse cornea (Visualization
2). En-face moxifloxacin TP (A1 - E1) and RC (A2 – E2) images at 5 different depths of
3µm, 15µm, 20µm, 33µm, 65µm from the surface are shown. (A1 and 2): the superficial
epithelium, (B1 and 2): the basal epithelium, (C1 and 2): the sub-basal nerve plexus (yellow
arrow), (D1 and 2): the stroma showing nerves (red arrow), (E1 and E2): the endothelium.
TP images are color-coded in green and blue scales for moxifloxacin fluorescence and SHG,
respectively. RC images are color-coded in gray scale.
3.3. Combined moxifloxacin TP and RC images in the mouse cornea and skin
Images in the moxifloxacin TPF/SHG and RC channels were combined to demonstrate the benefit
of multiple contrasts. Combined moxifloxacin TP and RC images of the mouse cornea and
skin are presented in Fig. 4. The combined images were made by using different colors for
individual contrasts: green, blue and red colors for moxifloxacin TPF, SHG and RC, respectively.
In case of the mouse cornea, individual images and a combined image of the corneal stroma
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were presented in Fig. 4(a-c). Individual images in the TPF and RC channels showed cells in the
corneal stroma such as keratocytes and nerves, but the individual images visualized different
features of the cells. Cell nuclei were mainly shown in the TPF channel owing to the variation of
moxifloxacin intracellular distribution (Fig. 4(a)). The overall shape of the cells including cell
cytoplasm was visualized in the RC channel owing to light reflection from the cell membrane
(Fig. 4(b)). Collagen in the corneal stroma was visible in the SHG channel (Fig. 4(a)). The
combined image of the corneal stroma showed both the nucleus and cytoplasm of cells in different
colors by combining the two individual images. In case of the mouse skin, individual images
and a combined image of the skin dermis was presented in Fig. 4(d-f). Individual images in the
moxifloxacin TPF/ SHG and RC channels showed different microstructures in the skin dermis. In
the moxifloxacin TPF channel, cells including individually distributed dermal cells, cell clusters
in the hair follicles (yellow arrowheads), endothelial cells on the wall of blood vessels (white
arrowheads), and nerves (purple arrowheads) were visualized (Fig. 4(d)). In the RC channel,
the distribution of ECM including fibrous structures and hair follicles were visualized based on
the variation of reflection intensity (Fig. 4(e)). Blood flows was visualized in the RC channel
owing to temporal intensity fluctuation during image acquisition. The combined image of the
skin dermis visualized cells, ECM structures, and blood flow altogether (Fig. 4(f)). Blood flow
appeared in high contrast via additional processing of temporal intensity variation. Some blood
flow was around the hair follicles, and others were across the dermis. Detail microenvironments
in the skin dermis were visualized by the combination of reflection, moxifloxacin TPF, and SHG.
Fig. 4. Combined en-face images of the mouse corneal stroma and skin dermis, in vivo.
(A-C): individual images of the corneal stroma in the moxifloxacin TPF/SHG (A) and RC
(B) channels and a combined image (C). In the combined image, the RC channel image
was color-coded in red for the enhanced contrast with the TPF/SHG channel image which
was color-coded in green and blue. (D-F): individual images of the skin dermis in the
moxifloxacin TPF/SHG (D) and RC (E) channels and a combined TPF/SHG and blood flow
image (F).
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3.4. Combined moxifloxacin TP and RC imaging of the human basal cell carcinoma
(BCC), ex vivo
Lastly, the combined microscopy was applied to human skin cancer specimens, and the imaging
results of a human basal cancer carcinoma (BCC) specimen are shown in Fig. 5. BCC is the most
common skin cancers. BCC specimens were selected as the sample for testing the combined
microscopy, because BCC is a skin cancer type with relatively clear cancer-normal tissue
boundary and BCC margin detection has been extensively studied by RCM [4,5]. A bright-field
image of the BCC specimen and two hematoxylin and eosin (H&E) labeled histological images
are shown in Fig. 5(a) and (b-c). The bright-field image showed a partially pigmented skin
specimen. Upper side of the specimen including pigmented region was BCC. H&E staining
histological images in two different field of views (FOVs) showed cancer cell distribution in the
specimen (Fig. 5(b-c)). A large FOV histological image showed BCC in the upper side and some
normal skin in the lower side (Fig. 5(b)). A zoomed histological image inside the BCC showed
cancer cell nest structures (Fig. 5(c)). Large-sectional combined images of the BCC specimen
and zoomed combined images at 3 regions of interest (ROIs) are shown in Fig. 5(d, e) and (f-h).
The large-sectional combined images were generated by mosaicking 16× 8 images acquired via
sample translation in a raster pattern. FOV of the mosaic image was approximately 5 mm x 3 mm
and the imaging took approximately 10 min. Combined images were presented in the TPF/SHG
and RC channels. The mosaic combined image showed dense cellular structures in the upper
left and entire mid-right sides and ECM rich structures on the lower left side in the TPF/SHG
channel, and meso-scale structures of BCC nests and surrounding fibers in the RC channel.
Moxifloxacin TP images identified two different regions: one consisting of high-density cells
and no ECM, and the other consisting of mostly ECM. On the other hand, RC images did not
distinguish the two regions clearly. Three regions of interest (ROIs) were selected in the mosaic
image for detail analysis. One inside the cancer region (ROI-1), one outside the cancer region
(ROI-2), and one on the border (ROI-3) were selected as marked in the mosaic image. Zoomed
images of the three ROIs showed different microstructures. The one inside the cancer (ROI-1)
showed cancer cell nests mostly. Cell clusters in the nests were shown in the TPF channel with
moxifloxacin labeling, and there was small portion of collagen in between cancer cell nests.
Individual cells were not resolvable due to little intensity difference on the cell boundaries, but
some cells could be identified with slight contrast among the cell nucleus and cytoplasm. In
the RC channel, morphologies of cancer cell nests were visible by expressing relatively high
reflection in the nest compared to in between the nests. Some cells inside the nests were resolvable
with the variation of reflection intensities. There was a fibrous structure on the lower left corner
of the image, and the fibrous structure was correlated with the collagen structure shown in the
TPF/SHG channel. In ROI-2, the zoomed combined image showed ECM structures mostly in the
TPF/SHG channel and fibrous structures in the RC channel. The TP image showed collagen and
elastin of the ECM and some scattered cells. Elastin fibers appeared clearly, because intrinsic AF
levels were strong enough. The scattered cells could not be identified exactly whether they were
stromal cells, inflammatory cells, or cancer cells. Because ROI-2 had intact ECM and BCC tends
not to invade as single cells, ROI-2 was considered as the normal region. The RC image showed
mostly fibrous structures which were different from BCC nests. In ROI-3, the zoomed combined
image showed the boundary between BCC nests and ECM rich regions. Both the BCC nests and
surrounding ECM were shown on the upper and lower sides of the image, respectively in the
TPF/SHG channel, and round nest structures and fibrous structures were shown on the upper and
lower sides in the RC channels, respectively. The TP image showed densely scattered cells on the
boundary and these could be immune cells. Other than the densely scattered cells, the lower
side of ROI-3 was similar to ROI-2. The RC image showed nest structures on the upper side and
fibrous structures on the lower side. Although normal skin tissue was shown in small portion of
the specimen, moxifloxacin TP and RC images provided information of microstructures in the
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Fig. 5. A bright-field image, histological images, and moxifloxacin TP and RC images
(5mm x3mm in size) of a human BCC specimen, ex vivo. (A): a bright-field image of
the BCC specimen. (B, C) hematoxylin and eosin (H&E) stained histological images in
two different scales. A cell-rich region in (B) was marked with a black dash lined square
and a zoomed image is shown in (C). (D, E) Large-sectional mosaic moxifloxacin TP and
RC images of the human BCC just below the surface. The moxifloxacin TP image was
color-coded in green and blue scales for moxifloxacin fluorescence and SHG, respectively.
The RC image was color-coded in gray scale. 3 region-of-interests (ROIs) are marked with
yellow dash lined squares and zoomed moxifloxacin TP and RC images of the 3 ROIs are
shown in (F1, 2 – H1, 2). (F1, 2): moxifloxacin TP and RC images of ROI-1 which is
abundant in cancer cells (Visualization 3). (G1-2): moxifloxacin TP and RC images of
ROI-2, which is abundant in ECM (Visualization 4). (H1-2): moxifloxacin TP and RC
images of ROI-3, which is on the boundary of the cell and ECM rich regions (Visualization
5). Marked with red dash lined squares are zoomed moxifloxacin TP and RC images (I1, 2).
(I1, 2): moxifloxacin TP and RC images of sebaceous gland.
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skin dermis. There was a cell cluster structure with distinct morphology on the right lower side
of the large sectional TP image, marked with a red dashed line rectangle (Fig. 5(i)). The cellular
structure was considered as a sebaceous gland, because an acinar structure like a many-lobed
berry was observed in the TPF channel. The sebaceous gland was observed in the RC channel
image, but its structure was not clearly differentiated from that of the cancer cell nest in the RC
channel.
4. Discussion
High-speed combined RC and moxifloxacin TP microscopy was developed for non-invasive
high-speed multi-modal imaging. The combined microscopy was to provide additional cell and
collagen contrasts to the reflection contrast of RCM and was implemented by using a Ti-Sapphire
laser. After the development and characterization, the high-speed combined microscopy was
applied to in-vivo normal mouse skin andmouse cornea, and ex-vivo human skin cancer specimens.
In the normal skin, both the RC and TPF channel images visualized cellular structure in the
epidermis similarly but they visualized different features in the dermis. The RC channel images
visualized fibrous ECM structure and vessels in the dermis. On the other hand, the TPF/SHG
channel images visualized cells in the dermis with moxifloxacin labeling and additional collagen
distribution in the ECM via SHG. The combined image showed the detail skin microenvironments
by visualizing cells, ECM, vasculature and blood flow. Additional cell and collagen contrasts in
the TPF/SHG channel images were useful for the visualization of human BCC specimens. The
TPF/SHG channel images visualized BCC nests imbedded in the dermis and ECM distribution.
On the other hand, RCM visualized BCC nests and fibrous ECM structures. Therefore, the
additional contrasts of cell and ECM by moxifloxacin TPM were useful for the visualization of
microstructures in BCC together with RCM. The same features of combined microscopy could
be used for the imaging of diseased corneas. In the normal cornea, the RC channel images
visualized cells in all the corneal layers owing to its transparency. The TPF/SHG channel images
visualized cells in the all the corneal layers based on moxifloxacin fluorescence and collagen
in the stroma based on SHG. Multiple contrasts in the combined microscopy showed epithelial
cells and stromal cells in two different contrasts and provided additional collagen information in
the normal cornea. Diseased corneas are not transparent due to the disruption of microstructure
in both the epithelium and stroma. Multiple contrasts of the combined microscopy would be
helpful for the precise detection and diagnosis in diseased corneas [28].
The level of excitation power used in this study was higher than what are used for in vivo
label-free TPM of human skin [29–32]: 2-5 mW for imaging the superficial epidermis and 10-40
mW for imaging the deep dermis. We used a fixed excitation power of 10-12 mW to image both
the epidermis and dermis of the skin due to lack of a fast power control mechanism, although
less excitation power could be used for imaging the epidermis. System upgrade for precise
power control is required for human applications. With the increase of scanning speed, the
excitation energy deposited on each position of the sample is decreased. Therefore, there is room
to increase the excitation power. The limitation of excitation power for moxifloxacin TPM needs
further study by taking nonlinear photodamage effects into consideration. Moxifloxacin has been
approved by the FDA for its use in normal and infected skin. However, it is unknown whether
intracellular moxifloxacin concentrations for fluorescence imaging is clinically safe. For clinical
trials, intracellular moxifloxacin concentrations should be determined beforehand to ensure the
clinical safety.
The combined RC and moxifloxacin TP microscopy would be useful in the clinical applications
of RCM, especially providing information during surgery. We anticipate moxifloxacin penetration
in the human skin is more challenging than the case in the mouse skin due to the thicker epidermis
owing to the more cell layers. During surgery, the skin barrier is removed and moxifloxacin is
rapidly absorbed into the tissue. The combined microscopy provides additional contrasts of cells
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and collagen to RCM without any compromise in the imaging speed. These additional contrasts
may be able to improve the sensitivity and specificity of optical microscopic examination. One
disadvantage of the combined microscopy over RCM is the increased cost by using femtosecond
pulse lasers as the light source. There are fixed wavelength femtosecond fiber lasers available at
relatively low costs compared to the laser used in this study, and the combined microscopy can use
the fixed wavelength laser without any disadvantage. The next step will be pre-clinical and clinical
studies of skin cancer specimens and corneal complications, and the verification of advantages
having additional contrasts in the clinical applications. The combined moxifloxacin TP and
RC microscopy system can be combined with other microscopic techniques providing different
contrasts to improve detection sensitivity. One example is coherent anti-Stokes Raman scattering
(CARS) microscopy. CARS microscopy will be useful by providing chemical information of
living tissues such as lipid and protein contents non-invasively. In particular, the additional lipid
contrast will be a good addition to the combined moxifloxacin TP and RC microscopy in brain
imaging for visualizing myelinated axons [33].
5. Conclusion
The combined RC and moxifloxacin TP microscopy was developed to overcome the limited
contrast of RCM while keeping its advantages such as high imaging speeds and non-invasiveness.
The combined microscopy could non-invasively visualize detail microstructures of tissues
including cells, ECM, vasculature and blood flow by using multiple contrasts of reflectance,
fluorescence and SHG. The combined microscopy might be useful for clinical applications of
RCM by providing multi-contrast information.
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